Nan-Hee Kim

21PUBLICATIONS
72CO-AUTHORS
Molecular targetsBehavioural epidemiologyPharmacogenomicsMedical biochemistry - lipidsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 22, 2026
SGLT2 inhibition modulates metabolic, vascular, and inflammatory molecular markers in the kidney in youth with type 1 diabetes.

|Nov 12, 2025
Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL study.

David C Wheeler, Kevin M Pantalone, Lixin Guo

|Sep 16, 2025
Efficacy and safety in tirzepatide-treated Korean adults with type 2 diabetes-A post hoc analysis of SURPASS-AP-combo and SURPASS-3.

Byung Wan Lee, Chang Beom Lee, Soo Lim

|Feb 07, 2025
Association of metabolic dysfunction-associated fatty liver disease with white matter hyperintensity and cognitive decline: A longitudinal cohort study.

Inha Jung, So Young Park, Da Young Lee

|Jan 03, 2025
Risk acceleration by gout on major adverse cardiovascular events and all-cause death in patients with diabetes and chronic kidney disease.

Da Young Lee, Jun Sung Moon, Inha Jung

|Aug 05, 2024
Effect of gout and diabetic kidney disease on renal cancer development in Korea.

Seung Min Chung, Inha Jung, Da Young Lee

Pageof 4

Frequent Collaborators

7 joint publications

Kyung Mook Choi

4 joint publications

Da Young Lee

4 joint publications

Hye Jin Yoo

4 joint publications

Sin Gon Kim